adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in patients with res...
Published 3 years ago • 402 plays • Length 4:59Download video MP4
Download video MP3
Similar videos
-
3:49
nivolumab alone versus nivolumab plus ipilimumab in patients with resectable hcc
-
2:57
neoadjuvent ipilimumab plus nivolumab beneficial compared to adjuvent nivolumab in macroscopic, ...
-
10:05
nivolumab alone superior to ipilimumab alone in advanced melanoma
-
5:18
neoadjuvant ipilimumab and nivolumab immunotherapy for resectable stage iii melanoma
-
2:14
hcrn mel17-309: phase ii study of adjuvant nivolumab with ipilimumab in high-risk uveal melanoma
-
2:22
adjuvant nivolumab in patents with high-risk resected melanoma
-
7:34
adjuvant therapy for melanoma: nivolumab, pembrolizumab, ipilimumab, dabrafenib and trametinib
-
27:18
adjuvant and neoadjuvant dilemmas
-
9:32
checkmate 648: nivolumab plus ipilimumab or nivo plus chemo versus chemo as (1l) treatment for a...
-
9:09
nivolumab with alternatively scheduled ipilimumab in first-line treatment of advanced rcc
-
3:31
comment: adjuvant ipilimumab in high-risk melanoma
-
2:08
nivolumab with ipilimumab for mrcc
-
5:28
ipilimumab as adjuvant therapy improves os in high risk melanoma
-
6:35
phase iii study finds initial nivolumab-based treatment halts melanoma progression
-
6:24
initial nivolumab-based treatment halts melanoma progression
-
2:10
dr. weber on the toxicity profile of nivolumab versus ipilimumab for melanoma
-
2:14
immuned: adjuvant nivolumab and ipilimumab increases os in stage iv melanoma
-
2:04
benefits and risks of reinduction ipilimumab/nivolumab in patients with melanoma
-
1:24
dr. atkins on adjuvant ipilimumab in melanoma